{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:54Z","timestamp":1793214654050,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T00:00:00Z","timestamp":1480723200000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ophtha.2016.07.029","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T01:36:14Z","timestamp":1475285774000},"page":"2413-2423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA)"],"prefix":"10.1016","volume":"123","author":[{"given":"Quan Dong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline T.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Lloyd","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alay S.","family":"Banker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fardeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5440-667X","authenticated-orcid":false,"given":"Pablo","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc","family":"LeHoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-9328","authenticated-orcid":false,"given":"Sivakumar R.","family":"Rathinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Thurau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0650-1725","authenticated-orcid":false,"given":"Laura","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2016.07.029_bib1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","article-title":"Understanding uveitis: the impact of research on visual outcomes","volume":"30","author":"de Smet","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2016.07.029_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archopht.1962.00960030506014","article-title":"Epidemiology of uveitis","volume":"68","author":"Darrell","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib4","series-title":"Uveitis Update","first-page":"13","article-title":"Epidemiology of uveitis:preliminary results of a prospective study in the Savoy","author":"Vadot","year":"1984"},{"key":"10.1016\/j.ophtha.2016.07.029_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/09273949409057073","article-title":"Epidemiology of uveitis in Switzerland","volume":"2","author":"Tran","year":"1994","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2016.07.029_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0420.1997.tb00255.x","article-title":"Incidence and prevalence of different uveitis entities in Finland","volume":"75","author":"Paivonsalo-Hietanen","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2016.07.029_bib7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/bjo.84.7.706","article-title":"Population based assessment of uveitis in an urban population in southern India","volume":"84","author":"Dandona","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","article-title":"Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study","volume":"111","author":"Gritz","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.07.029_bib9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ajo.2008.09.014","article-title":"Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest","volume":"146","author":"Suhler","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","article-title":"Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.80.9.844","article-title":"The possible impact of uveitis in blindness: a literature survey","volume":"80","author":"Suttorp-Schulten","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ophtha.2010.03.029","article-title":"A\u00a0cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States","volume":"118","author":"Nguyen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.07.029_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11882-013-0409-1","article-title":"Noninfectious immune-mediated uveitis and ocular inflammation","volume":"14","author":"Pan","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.ophtha.2016.07.029_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2013.03.027","article-title":"Approach to the diagnosis of the uveitides","volume":"156","author":"Jabs","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib17","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.07.029_bib18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib19","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","article-title":"Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study","volume":"113","author":"Jaffe","year":"2006","journal-title":"Ophthalmology"},{"issue":"Suppl","key":"10.1016\/j.ophtha.2016.07.029_bib20","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ophtha.2016.07.029_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","article-title":"Regulation of immune responses by mTOR","volume":"30","author":"Powell","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/02713689308999487","article-title":"Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction","volume":"12","author":"Roberge","year":"1993","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2016.07.029_bib23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4049\/jimmunol.154.2.922","article-title":"Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis","volume":"154","author":"Martin","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib24","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.2004.048199","article-title":"The efficacy of sirolimus in the treatment of patients with refractory uveitis","volume":"89","author":"Shanmuganathan","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/jop.2011.0226","article-title":"Tolerability and pharmacokinetics of intravitreal sirolimus","volume":"28","author":"Mudumba","year":"2012","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2016.07.029_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1869-5760-3-32","article-title":"Ocular tolerability and efficacy of intravitreal and subconjunctival injections of\u00a0sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study","volume":"3","author":"Nguyen","year":"2013","journal-title":"J\u00a0Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.ophtha.2016.07.029_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.4.2.4","article-title":"One-year outcomes of the SAVE Study: Sirolimus as a Therapeutic Approach for UVEitis","volume":"4","author":"Ibrahim","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib28","unstructured":"Levinson R. Management of chronic uveitis. Focal Points; 2007;11:1\u201318."},{"key":"10.1016\/j.ophtha.2016.07.029_bib29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.transproceed.2006.01.044","article-title":"Side effects of sirolimus","volume":"38","author":"Merkel","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ophtha.2016.07.029_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2415-12-9","article-title":"A\u00a04-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 \u03bcg\/mL to latanoprost 50 \u03bcg\/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension","volume":"12","author":"Eveleth","year":"2012","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.07.029_bib31","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Adamis","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2016.07.029_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2011.03.020","article-title":"The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing","volume":"118","author":"Heier","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.07.029_bib33","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","article-title":"Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials RISE and RIDE","volume":"120","author":"Brown","year":"2013","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016307357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016307357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T09:04:29Z","timestamp":1692522269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642016307357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0161642016307357"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.029","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA)","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}